Clinical Trials Sponsored by Genfit

Total 151 results

Genfit

Recruiting

Combination of GNS561 and Trametinib in Patients With Advanced KRAS Mutation Cholangiocarcinoma

Cholangiocarcinoma

United States, Puerto Rico
Genfit

Completed

Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

Insulin Resistance | Abdominal Obesity

France
Genfit

Completed

Pilot Study With GFT505 (80mg) in Patients Presenting With Impaired Glucose Tolerance and Abdominal Obesity.

Impaired Glucose Tolerance | Abdominal Obesity

France
Genfit

Completed

Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects

Renal Impairment | Kidney Disease | Renal Disease

United States
Genfit

Terminated

Phase 3 Study to Evaluate the Efficacy and Safety of Elafibranor Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH) (RESOLVE-IT)

Nonalcoholic Steatohepatitis (NASH) With Fibrosis

United States, Belgium, Germany, France, Canada, Netherlands, Italy, Switzerland, Finland, Puerto Rico, United Kingdom, Denmark, Spain, Australia, Czechia, Sweden, Romania, Argentina, Portugal, Turkey, Mexico, Colombia, South Africa, ... and more
Genfit

Terminated

Study to Evaluate the Effect of Elafibranor on Hepatic Lipid Composition in Subjects With Nonalcoholic Fatty Liver (NAFL)

Non-Alcoholic Fatty Liver

Netherlands
Genfit

Completed

Elafibranor Pharmacokinetic Parameters in Renal Impaired Patients

Kidney Diseases | Renal Insufficiency | Renal Impairment | Pharmacokinetics

France, Romania
Genfit

Completed

Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

Primary Biliary Cholangitis (PBC)

United States, United Kingdom, France, Germany, Spain
Genfit

Completed

Study With GFT505 (80mg) Versus Placebo in Patients With Type 2 Diabetes Mellitus

Type II Diabetes Mellitus

Bosnia and Herzegovina, Latvia, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Serbia
Genfit

Completed

Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients

Liver Diseases | Moderate Hepatic Impairment | Severe Hepatic Impairment

United States
Genfit

Terminated

Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH)

Non Alcoholic Steatohepatitis

United States
Genfit

Completed

Elafibranor Pharmacokinetic Parameters in Elderly Healthy Volunteers

Healthy | Geriatrics

France
Genfit

Completed

Study to Investigate the Potential Drug-Drug Interaction Between Elafibranor and Indomethacin

Drug-drug Interaction

France
Genfit

Completed

Pilot Study With GFT505 (80mg) in Atherogenic Dyslipidaemic Patients With Abdominal Obesity

Abdominal Obesity | Atherogenic Dyslipidaemia

France, Romania, Tunisia
Versantis AG

Recruiting

Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)™

Acute-On-Chronic Liver Failure | Ascites

Germany, Spain, Belgium, United States, France
Genfit
Naturalpha; SGS Aster S.A.S.

Completed

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Cardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | Obese

France
Genfit
Eurofins Optimed; PhinC Development; CardiaBase

Completed

Phase I Study to Evaluate the Effect of GFT505 on QT/QTc Interval in Healthy Volunteers

Healthy Volunteers

France
Genfit
Premier Research Group plc; Naturalpha

Completed

Phase IIb Study to Evaluate the Efficacy and Safety of GFT505 Versus Placebo in Patients With Non-Alcoholic Steatohepatitis (NASH)

Non-Alcoholic Steatohepatitis (NASH)

United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
Genfit
University of Miami; Syneos Health

Completed

Elafibranor Pharmacokinetic Parameters in Hepatic Impaired Patients

Pharmacokinetics | Hepatic Impairment | Liver Disease

United States
Emfit, Corp.

Unknown

Assessment of the Emfit Mattress Sensor for Detection and Alarm of Night-time Generalized Tonic-clonic Seizures.

Epilepsy | Seizures

United States
Genfit
SGS Life Sciences, a division of SGS Belgium NV

Completed

Mass Balance Study of 14C-labelled GFT505 in Healthy Volunteers

Healthy

Belgium
TBF Genie Tissulaire

Not yet recruiting

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis

Osteoarthritis Hand

France
TBF Genie Tissulaire

Recruiting

Treatment of Ano-perineal Fistulas Resistant to Surgical Treatment With a Gel and Plug of Wharton's Jelly

Anal Fistula

France
TBF Genie Tissulaire

Recruiting

Use of a Nerve Regeneration Conduit (NerVFIX®) in the Treatment of Nerve Section of the Wrist

Nerve Injury | Nerve Lesion

France
TBF Genie Tissulaire

Completed

Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis

Corneal Ulcer | Keratitis, Ulcerative

France
TBF Genie Tissulaire

Completed

Use of an Allograft Set-up (SclerFIX) as Replacement of Sclera Graft for Support of Enucleation Implant

Enucleated; Eye | Eye Cancer

France
TBF Genie Tissulaire

Terminated

Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

Retinal Detachment | Macular Holes

France
TBF Genie Tissulaire

Terminated

Use of a Disk of Amniotic Membrane (Visio-AMTRIX) in Postoperative Care After PKR

Astigmatism | Myopia | Hypermetropia

France
TBF Genie Tissulaire

Withdrawn

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers

Corneal Ulcer | Persistent Corneal Epithelial Defect
TBF Genie Tissulaire

Terminated

Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Treatment-Resistant Keratitis

Keratitis

France
Herlev Hospital
GENIS

Terminated

Gemcitabine and Capecitabine With or Without T-ChOS as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (CHIPAC)

Pancreatic Cancer

Denmark
TBF Genie Tissulaire

Terminated

Comparison of Microfracture Treatment and CARTIPATCH® Chondrocyte Graft Treatment in Femoral Condyle Lesions

Osteochondral Defect | Knee Chondral

Belgium
TBF Genie Tissulaire

Not yet recruiting

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis

Osteoarthritis Hand

France
TBF Genie Tissulaire

Active, not recruiting

Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications

Stress Urinary Incontinence | Female Stress Incontinence

France
TBF Genie Tissulaire

Recruiting

Evaluation of SclerFIX Graft in Scleral Thinning After Exeresis of Tumors of the Ocular Surface

Scleral Thinning

France
TBF Genie Tissulaire

Active, not recruiting

Use of a Treated, Devitalized and Sterile Meniscus Segment (MENISC-T) in the Treatment of Scaphotrapeziotrapezoid Osteoarthritis

Osteoarthritis Hand

France
TBF Genie Tissulaire

Terminated

Second Line Treatment of Knee Osteochondral Lesion With Treated Osteochondral Graft (ODPHOENIX2)

Cartilage Injury
TBF Genie Tissulaire

Terminated

OD-PHOENIX in Talus Osteochondral Lesion (TBF3)

Talus Osteochondral Defect

Belgium, Israel
Herlev Hospital
GENIS

Terminated

Pharmacokinetic Profile of T-ChOS™ in Subjects With Advanced Solid Tumors (CHITIN) (CHITIN)

Advanced Solid Tumors

Denmark
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Not yet recruiting

A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR).

Allergic Rhinitis
University of Exeter
OpenFit LLC

Recruiting

Does a Multi-ingredient Pre-workout Supplement Enhance Cycling Time Trial Performance? (MIPS)

Healthy Volunteers

United Kingdom
Spanish Oncology Genito-Urinary Group

Completed

Clinical Trial With Vinflunine as Maintenance Therapy in Metastatic Urothelial Cancer (MAJA)

Carcinoma, Transitional Cell

Spain
Spanish Oncology Genito-Urinary Group

Completed

Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib (Spazo-2)

Metastatic Renal Cell Carcinoma

Spain
Spanish Oncology Genito-Urinary Group

Completed

Clinical Trial of Dovitinib in First-line Metastatic or Locally Advanced Non-resectable Adrenocortical Carcinoma

Adrenocortical Carcinoma

Spain
Spanish Oncology Genito-Urinary Group

Completed

Sunitinib in Patients With Renal Cells Carcinoma Metastasic or Locally Avanced in Patients Not Candidates to Curative Previous Nefrectomy (SOGUG/0107)

Carcinoma Renal Cells

Spain
Spanish Oncology Genito-Urinary Group

Completed

Clinical Trial on the Mixture of G, C and S in Treatment of Patients With RCC (SOGUG-02-06)

Carcinoma, Renal Cell

Spain
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Not yet recruiting

Phase III Study of GR1802 Injection in Patients With Atopic Dermatitis

Atopic Dermatitis

China
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Not yet recruiting

The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps

Chronic Rhinosinusitis With Nasal Polyps
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE

Lupus Erythematosus, Systemic

China
Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Recruiting

The Study of Single Dose Administration of GR2002 Injection in Chinese Health Volunteers

Asthma

China

3

Subscribe